Fluvastatin
Back to searchMolecule Structure
Scientific Name
Fluvastatin
Description of the Drug
Fluvastatin is an HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01095
http://www.drugbank.ca/drugs/DB01095
Brand Name(s)
Not Available
Company Owner(s)
Novartis Pharmaceuticals Corp, Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc, Beijing Sciecure Pharmaceutical Co Ltd, Teva Pharmaceuticals Usa
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
HMG-CoA reductase | SINGLE PROTEIN | INHIBITOR | CHEMBL402 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL2848 | ||
DrugBank | DB01095 | ||
PubChem: Thomson Pharma | 14855380 | ||
PubChem | 5353627 | ||
LINCS | LSM-43301 | ||
rxnorm | LESCOL | FLUVASTATIN | FLUVASTATIN SODIUM |
ChEBI | 38562 |